Phase I study of vincristine, irinotecan, and (1)(3)(1)I-metaiodobenzylguanidine for patients with relapsed or refractory neuroblastoma: a new approaches to neuroblastoma therapy trial - DuBois, S G; Chesler, L; Groshen, S (Clin Cancer Res, 2012)